(Q36565145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

review article

1 reference

title

The use of clostridial spores for cancer treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Jozef Anné

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

S Barbé

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

Journal of Applied Microbiology

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

571-578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16907807%20AND%20SRC:MED&resulttype=core&format=json

Bacteriolytic therapy can generate a potent immune response against experimental tumors

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

BCG immunotherapy of bladder cancer: 20 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Exploiting tumour hypoxia in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Combination bacteriolytic therapy for the treatment of experimental tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Replication-selective oncolytic viruses in the treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Further Progress with Oncolysis due to Local High Frequency Hyperthermia, Local X-Irradiation and Apathogenic Clostridia*

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

The liquefaction (oncolysis) of malignant gliomas by a non pathogenic Clostridium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Colonisation of Clostridium in the body is restricted to hypoxic and necrotic areas of tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Clostridia in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Tumor necrosis factor as an antineoplastic agent: pitfalls and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Measurements of hypoxia using pimonidazole and polarographic oxygen-sensitive electrodes in human cervix carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Effect of Histolyticus Infection and Toxin on Transplantable Mouse Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Bacteria as tumour-targeting vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

The hypoxic tumour microenvironment and metastatic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Tumor-specific gene delivery using genetically engineered bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X

Bifidobacterium longum as a delivery system for cancer gene therapy: selective localization and growth in hypoxic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.02886.X